Log in

Start free trial
Home 5 Lab Industry Advisor 5 Laboratory Industry Report 5 FDA-lir 5 FDA Watch: New Guidance on Charging for Investigational Drugs

FDA Watch: New Guidance on Charging for Investigational Drugs

by | Aug 31, 2022 | FDA-lir, Laboratory Industry Report

On August 21, the FDA proposed new guidelines on charging for investigational drugs; here are the key highlights.

Illustration of red and clear pills with dollar bills inside to represent investigational new drug fees. Stock illustration.

On August 21, the FDA proposed new guidelines on charging for investigational drugs; here are the key highlights.

This content is for Paid Members only.
Login Register